Baxter International (BAX) Long-Term Debt Issuances (2009 - 2025)
Baxter International's (BAX) quarterly Long-Term Debt Issuances came in at $600.0 million in Q4 2025, up 172.55% year-on-year from $220.1 million in Q4 2024, and down 11.76% on a QoQ basis from $680.0 million in Q2 2025.
Baxter International (BAX) Long-Term Debt Issuances (2009 - 2025) Analysis & Trends
Baxter International (BAX) has 16 years of Long-Term Debt Issuances data on file, last reported at $600.0 million in Q4 2025.
- On a quarterly basis, Long-Term Debt Issuances rose 172.55% year-over-year to $600.0 million in Q4 2025; TTM through Mar 2026 was $1.3 billion, a 54.45% decrease from a year earlier, with the FY2025 full-year figure at $2.0 billion, changed N/A from the prior year.
- Long-Term Debt Issuances for Q4 2025 stood at $600.0 million, down from $680.0 million in the prior quarter.
- Over the last five years, Long-Term Debt Issuances for BAX reached as high as $11.9 billion in Q4 2021 and fell as low as -$827.0 million in Q4 2024.
- Historically, Long-Term Debt Issuances has averaged $1.2 billion across 5 years, with a median of $278.0 million in 2022.
- Across the five-year window, Long-Term Debt Issuances jumped 228000.0% in 2023 and plunged 136.26% in 2024, its largest moves.
- Year by year, Long-Term Debt Issuances stood at $11.9 billion in 2021, then tumbled by 99.99% to $1.0 million in 2022, then soared by 228000.0% to $2.3 billion in 2023, then plunged by 136.26% to -$827.0 million in 2024, then soared by 172.55% to $600.0 million in 2025.
- Per Business Quant data, the three most recent Long-Term Debt Issuances figures were $600.0 million in Q4 2025, $680.0 million in Q2 2025, and $2.8 billion in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 40.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 857.70 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 600.00 Mn |
| Dec 31, 2025 | 600.00 Mn |
| Jun 30, 2025 | 680.00 Mn |
| Jun 30, 2025 | 680.00 Mn |
| Mar 31, 2025 | 2.83 Bn |
| Mar 31, 2025 | 2.83 Bn |
| Dec 31, 2024 | -827.00 Mn |
| Dec 31, 2024 | -827.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 809.00 Mn |
| Jun 30, 2024 | 809.00 Mn |
| Mar 31, 2024 | 15.00 Mn |
| Mar 31, 2024 | 15.00 Mn |
| Dec 31, 2023 | 2.28 Bn |
| Dec 31, 2023 | 2.28 Bn |
| Sep 30, 2023 | 211.00 Mn |
| Sep 30, 2023 | 211.00 Mn |
| Jun 30, 2023 | 139.00 Mn |
| Jun 30, 2023 | 139.00 Mn |